Target intelligence / Profile preview

Lipopolysaccharide and Bacterial Outer Membrane (LPS)

Target
LPS
Molecular classification
Glycolipid, Bacterial cell wall component, Endotoxin
01

Overview

The bacterial outer membrane is a unique structural feature of Gram-negative bacteria, characterized by an asymmetric bilayer where the outer leaflet is primarily composed of lipopolysaccharide (LPS) (Raetz & Whitfield, 2002, Annual Review of Biochemistry). Lipid A is the highly conserved, hydrophobic anchor of LPS and serves as the primary mediator of endotoxic activity by triggering the TLR4 signaling pathway in host immune cells (Park & Lee, 2013, Experimental & Molecular Medicine). This structure acts as a formidable permeability barrier, protecting the bacterium from environmental stressors and many classes of antibiotics (Nikaido, 2003, Microbiology and Molecular Biology Reviews). Therapeutically, the outer membrane and Lipid A are targeted by polymyxins, which disrupt membrane integrity through electrostatic interactions with negatively charged phosphate groups (Poirel et al., 2017, Clinical Microbiology Reviews). Emerging therapies also focus on inhibiting the transport machinery, such as the Lpt pathway, that assembles LPS at the cell surface (Sperandeo et al., 2019, BBA - Molecular and Cell Biology of Lipids). Targeting this component is critical for treating multidrug-resistant Gram-negative infections, though it carries risks such as nephrotoxicity and the potential for massive endotoxin release during bacterial lysis (Zavascki et al., 2007, Journal of Antimicrobial Chemotherapy).

Other names
Lipid AEndotoxinGram-negative outer membraneLPS
02

Mechanism of action

Disruption of outer membrane integrity via displacement of divalent cations from Lipid A phosphate groups; inhibition of LPS transport proteins (e.g., LptD).

03

Biological functions

Structural integrityPermeability barrierImmune system activationEndotoxic activity
04

Disease associations

Gram-negative bacterial infectionSepsisSeptic shockInflammation
05

Safety considerations

NephrotoxicityNeurotoxicityEndotoxin release syndromeJarisch-Herxheimer reaction
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

ProcalcitoninLPS-binding protein (LBP)Soluble CD14Endotoxin activity assay (EAA)

Beyond the preview

Go deeper on Lipopolysaccharide and Bacterial Outer Membrane (LPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide and Bacterial Outer Membrane (LPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call